Quick Answer
COGNITION THERAPEUTICS INC reported Total Assets of $48.39 million for the year ending 2025.
- COGNITION THERAPEUTICS INC showed an increase of +60.1% in Total Assets from 2024 to 2025.
- This data is from COGNITION THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: $13.39 million | Q1 2022: $58.70 million | Q2 2022: $52.81 million | Q3 2022: $53.56 million | Q1 2023: $45.66 million | Q2 2023: $43.96 million | Q3 2023: $38.77 million | Q1 2024: $38.85 million | Q2 2024: $34.37 million | Q3 2024: $27.58 million | Q1 2025: $23.50 million | Q2 2025: $19.62 million | Q3 2025: $43.40 million.
- Over the full 6 years of available data (2020 to 2025), COGNITION THERAPEUTICS INC's Total Assets has grown by 579.7%.
- Historical annual values: Fiscal year 2025: $48.39 million | Fiscal year 2024: $30.23 million | Fiscal year 2023: $35.16 million | Fiscal year 2022: $50.43 million | Fiscal year 2021: $59.14 million | Fiscal year 2020: $7.12 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: